Summary
Long-term safety extension
Study Details
Study Design
Open-label extension
Indication
Female HSDD
Intervention
Bremelanotide 1.75 mg SC
Species
Human
Risk of Bias Assessment
Industry-sponsored
Tags
SourceExtensionBremelanotideReconnectHSDD
Metrics
Citations
0Evidence QualityN/A
Related PeptideBremelanotide8 papers